|
HAUS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.813500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.101440E-03 |
| Normal-vs-Stage2 |
3.056500E-03 |
| Normal-vs-Stage3 |
4.175200E-04 |
| Normal-vs-Stage4 |
5.74540000000123E-05 |
| Stage1-vs-Stage2 |
4.901800E-01 |
| Stage1-vs-Stage3 |
3.020800E-01 |
| Stage1-vs-Stage4 |
1.328190E-01 |
| Stage2-vs-Stage3 |
9.485000E-01 |
| Stage2-vs-Stage4 |
5.492200E-01 |
| Stage3-vs-Stage4 |
5.051000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.359900E-04 |
| Normal-vs-AfricanAmerican |
1.970200E-01 |
| Normal-vs-Asian |
1.088420E-02 |
| Caucasian-vs-AfricanAmerican |
2.372600E-01 |
| Caucasian-vs-Asian |
6.695800E-01 |
| AfricanAmerican-vs-Asian |
4.501600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.987900E-04 |
| Normal-vs-Female |
4.372600E-04 |
| Male-vs-Female |
4.538800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.077700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.367000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.91510000000705E-05 |
| Normal-vs-Age(81-100Yrs) |
1.726810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.075200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.170100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.461600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.607600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.346600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.415200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.861970E-01 |
| Classical-VS-Follicular |
3.975500E-03 |
| Classical-VS-Other |
5.627700E-02 |
| Classical-VS-Normal |
6.041700E-03 |
| Tall-VS-Follicular |
5.258000E-01 |
| Tall-VS-Other |
2.716600E-01 |
| Tall-VS-Normal |
4.922000E-03 |
| Follicular-VS-Other |
4.970000E-01 |
| Follicular-VS-Normal |
4.40680000000082E-05 |
| Other-VS-Normal |
4.557900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.359380E-04 |
| Normal-vs-N1 |
7.76670000000035E-05 |
| N0-vs-N1 |
3.268600E-01 |
|
|
